Sleep-Wake Disorders

Drs Paul Doghramji and Leslie Citrome share approaches to communicate with patients and increase awareness of insomnia disorder

Leslie Citrome, MD, MPH, comments on long-term data for daridorexant, suvorexant, and lemborexant.

Experts discuss daridorexant efficacy and safety data, and dosing considerations and what to communicate with patients when using daridorexant for insomnia.

Drs Paul Doghramji and Leslie Citrome provide an overview of dual orexin receptor antagonists (DORAs), suvorexant, lemborexant, and daridorexant, in treatment of insomnia disorder.

New research explores the impact of GAT on TGNC youth.

Drs Paul Doghramji and Leslie Citrome discuss the sleep and wakefulness signals and pathways that contribute to insomnia.

Drs Paul Doghramji and Leslie Citrome review the use of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) to assess treatment efficacy.

Experts discuss treatment for patients experiencing insomnia in conjunction with other health conditions.

Drs Paul Doghramji and Leslie Citrome review prescription drugs and over-the-counter remedies for treating insomnia.

Experts highlight cognitive behavioral therapy for insomnia (CBTI) and sleep hygiene as nonpharmacological approaches to the treatment of insomnia.

Drs Paul Doghramji and Leslie Citrome discuss daytime sleepiness and other symptoms of insomnia and their impact on quality of life.

Experts review the co-occurrence of insomnia with other medical conditions and discuss risks and triggers that lead to insomnia, such as age and psychiatric conditions.

Drs Paul Doghramji and Leslie Citrome provide an overview of the diagnosis and prevalence of insomnia.

Connections between autism risk, sleep disturbances, insomnia risk genes and circadian pathways were analyzed.

From herbal medicine for psychiatrists to the psychiatric implications of the Parkland School massing shooting, here are highlights from the week in Psychiatric Times.

Does the YOI intervention improve mental health workers’ insomnia? Research says yes.

Good night, sleep tight! Researchers performed a 9-year follow-up of sleep disturbance and ADHD symptoms in a population-based cohort study.

An expert panel concludes the discussion by reviewing factors to consider when diagnosing and treating narcolepsy.

A group of specialists discuss treatment options for patients experiencing daytime sleepiness and anxiety.

Thought leaders discuss what elements to consider when distinguishing between cataplexy and pseudo cataplexy.

Thomas E. Scammell, MD reviews the history and current symptoms of a patient with narcolepsy.

Thought leaders consider the role of newer medications in the therapeutic landscape.

In this installment of the Around the Practice custom video program, doctors discussed management of narcolepsy.

Digital therapeutics may be poised to step up as the next CBT.

The average patient with bipolar disorder struggles with sleep disorders. Here's how you can help.